Sou-ichi Makino

Title: Sou-ichi Makino: Innovator in Transgenic Plant Vaccines

Introduction

Sou-ichi Makino is a prominent inventor based in Obihiro, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of plant-based vaccines. His innovative approach aims to address agricultural and veterinary challenges through genetic engineering.

Latest Patents

One of Sou-ichi Makino's notable patents is titled "Transgenic plants expressing STX2EB protein for use as a pig edema disease vaccine." This technology focuses on producing a pig edema disease vaccine at low cost and with high efficiency. Specifically, it involves the efficient expression of a gene encoding the Stx2e protein, a toxin associated with pig edema disease, in plant cells. By utilizing the 5'-untranslated region of an alcohol dehydrogenase gene derived from plants, the Stx2e protein, which includes a secretory signal peptide, is expressed in plant cells, leading to the production of a cost-effective plant vaccine.

Career Highlights

Throughout his career, Sou-ichi Makino has worked with notable organizations, including Idemitsu Kosan Company, Limited and the Nara Institute of Science and Technology. His work has been instrumental in advancing the field of transgenic plants and their applications in veterinary medicine.

Collaborations

Sou-ichi Makino has collaborated with esteemed colleagues such as Kazutoshi Sawada and Kazuya Yoshida. These partnerships have contributed to the successful development of innovative solutions in biotechnology.

Conclusion

Sou-ichi Makino's work in developing transgenic plant vaccines represents a significant advancement in agricultural biotechnology. His innovative approach not only addresses the challenges of pig edema disease but also paves the way for future research in plant-based vaccines.